首页> 外文OA文献 >A multicenter prospective study on the efficacy and safety of denosumab in gastrointestinal cancer patients receiving short-term periodic steroid premedication for prevention of chemotherapy-induced nausea and vomiting (ESPRESSO-02/HGCSG1602).

【2h】

A multicenter prospective study on the efficacy and safety of denosumab in gastrointestinal cancer patients receiving short-term periodic steroid premedication for prevention of chemotherapy-induced nausea and vomiting (ESPRESSO-02/HGCSG1602).

机译：多中心前瞻性研究胃肠道癌患者的疗效和安全性接受胃肠道癌患者的短期周期性类固醇预防预防化疗诱导的恶心和呕吐（ESPRESSO-02 / HGCSG1602）。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Michio Nakamura; Tetsuhito Muranaka; Masataka Yagisawa; Yasuyuki Kawamoto; Satoshi Yuki; Atsushi Ishiguro; Masayoshi Dazai; Yoshimitsu Kobayashi; Susumu Sogabe; Kazuaki Harada; Kentaro Sawada; Takuto Miyagishima; Yasushi Tsuji; Yasuka Kikuchi; Yoshito Komatsu;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. TRIAL IN PROGRESS: A MULTICENTER PROSPECTIVE STUDY ON THE EFFICACY AND SAFETY OF DENOSUMAB IN GASTROINTESTINAL CANCER PATIENTS RECEIVING SHORT-TERM PERIODIC STEROID PREMEDICATION FOR PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (ESPRESSO-02) [J] . Muranaka T., Nakamura M., Yagisawa M., Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA . 2018,第Suppla1期

机译：审判正在进行中：对胃肠癌患者的胃肠癌患者疗效和安全性的多中心前瞻性研究，接受短期的周期性类固醇预防预防化疗诱导的恶心和呕吐（浓缩咖啡-02）
2. TRIAL IN PROGRESS: A MULTICENTER PROSPECTIVE STUDY ON THE EFFICACY AND SAFETY OF DENOSUMAB IN GASTROINTESTINAL CANCER PATIENTS RECEIVING SHORT-TERM PERIODIC STEROID PREMEDICATION FOR PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (ESPRESSO-02) [J] . Muranaka T., Nakamura M., Yagisawa M., Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA . 2018,第Suppla1期

机译：审判正在进行中：对胃肠癌患者的胃肠癌患者疗效和安全性的多中心前瞻性研究，接受短期的周期性类固醇预防预防化疗诱导的恶心和呕吐（浓缩咖啡-02）
3. Efficacy of aprepitant for the prevention of chemotherapy-induced nausea and vomiting with a moderately emetogenic chemotherapy regimen: a multicenter, placebo-controlled, double-blind, randomized study in patients with gynecologic cancer receiving paclitaxel and carboplatin [J] . Yahata Hideaki, Kobayashi Hiroaki, Sonoda Kenzo, International journal of clinical oncology . 2016,第3期

机译：阿瑞匹坦在中度致呕的化疗方案下预防由化疗引起的恶心和呕吐的功效：一项接受紫杉醇和卡铂的妇科癌症患者的多中心，安慰剂对照，双盲，随机研究
4. Efficacy and safety of 5 mg olanzapine for nausea and vomiting management in cancer patients receiving carboplatin: integrated study of three prospective multicenter phase II trials [O] . Senri Yamamoto, Hirotoshi Iihara, Ryuji Uozumi, 2021

机译：癌症患者治疗癌症患者的疗效和安全性5毫克奥氮藻的疗效和安全性：三个前瞻性期二期试验的综合研究
5. A multicenter prospective study on the efficacy and safety of denosumab in gastrointestinal cancer patients receiving short-term periodic steroid premedication for prevention of chemotherapy-induced nausea and vomiting (ESPRESSO-02/HGCSG1602) [O] . M. Nakamura, T. Muranaka, M. Yagisawa, 2018

机译：胃肠道癌患者患者患者胃肠癌患者疗效和安全性的多中心预期研究，用于预防化疗诱导的恶心和呕吐物（浓缩咖啡-02 / hgCSG1602）

A multicenter prospective study on the efficacy and safety of denosumab in gastrointestinal cancer patients receiving short-term periodic steroid premedication for prevention of chemotherapy-induced nausea and vomiting (ESPRESSO-02/HGCSG1602).

著录项

引文网络

相似文献

相关主题

期刊订阅